Cite
HARVARD Citation
Danese, S. et al. (n.d.). DOP72 Safety, tolerability and efficacy of anti-TL1A antibody PF-06480605 in treatment of ulcerative colitis: The open-label, multicentre, Phase 2a TUSCANY study. Journal of Crohn's and colitis. pp. S108-S110. [Online].